Significant Unmet Needs
Fibralign is an award-winning, Stanford-spinout company that produces novel therapeutic biomedical devices that are designed to address major unmet medical needs.
The company has launched its first product, the BioBridge Collagen Matrix, which has received FDA 510(k) clearance for use in soft tissue repair. The company is currently studying BioBridge for use in treating secondary lymphedema, a global chronic disease that currently has no cure
BioBridge® Collagen Matrix
- FDA 510(k) cleared device for use in soft tissue repair.
- BioBridge currently being studied for use in treating secondary lymphedema.
- FDA 510(k) cleared device*
- CE mark approved, Class III device
- Commercially available now in the US and Europe
* BioBridge has not been approved by the FDA for treating secondary lymphedema.
Fibralign is developing a pipeline of compelling novel products which are based on its proprietary Nanoweave® scaffolding platform that can be tailored to address a wide range of high-value applications. Nanoweave technology provides the means to precisely print 3D scaffolding in such a way that mimics human tissue nano structure and directly influence the body’s repair function.
Grants, Awards, Partners and Collaborators
Fibralign has been recognized for its vision and potential to impact lives globally. We are supported in our mission by world class partners and collaborators.
AngelMD,an investment and networking platform connecting innovative medical startups, physicians, investors, and industry partners, today announced that it has completed a Syndicate funding round for Fibralign, Inc. Fibralign produces therapeutic medical devices that...
Fibralign Corporation, a developer of advanced therapeutic medical devices, announces the appointment of Dimitris Dionysiou, Ph.D., M.D. as its Chief Medical Officer. Dr. Dionysiou joins the Company during the clinical phase for its first product, the BioBridge®...
Study shows nanofiber scaffolds could treat lymphedema by rerouting lymphatic system around blockage
Researchers at the School of Medicine have developed a possible treatment for lymphedema, the severe swelling of an arm or leg that can occur when the lymph system is blocked. Using scaffolding composed of specially patterned collagen nanofibers, the researchers...